News & Updates

An artificial intelligence (AI)-based model, dubbed AI-Thyroid, for the diagnosis of thyroid cancer demonstrates its utility in improving diagnostic performance and interobserver agreement, which could be helpful in less-experienced physicians, reports a study.

Administration of surfactant into the oropharynx of neonates delivered before 29 weeks of gestation falls short of reducing the rate of intubation in the first 120 hours of life, according to the results of POPART*.

In the treatment of patients with IgA nephropathy, the use of sibeprenlimab, a humanized IgG2 monoclonal antibody that binds to and neutralizes a proliferation-inducing ligand (APRIL), appears to lead to a significant reduction in proteinuria, according to a phase II trial.

The glucagon/GLP-1 receptor dual agonist survodutide appears to be safe and induce weight loss in individuals with obesity, according to data from a phase II dose-finding trial.

Treatment with the anti-influenza A virus inhibitor onradivir is safe and leads to symptom improvement and viral load reduction in adults with uncomplicated influenza infection, according to data from a phase II trial.

Addressing social isolation and loneliness in people with obesity can counter their increased risk of death, according to a study.